{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:24:59Z","timestamp":1792671899071,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1245\/s10434-021-10642-6","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T18:05:38Z","timestamp":1629914738000},"page":"188-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"29","author":[{"given":"Alfonso","family":"Garc\u00eda-Fadrique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Estevan Estevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Sabater Ort\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"issue":"4","key":"10642_CR1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-0009.2005.00397.x","volume":"83","author":"A Donabedian","year":"2005","unstructured":"Donabedian A. Evaluating the quality of medical care approaches to assessment: what to assess. Milbank Q. 2005;83(4):691\u2013729.","journal-title":"Milbank Q."},{"key":"10642_CR2","unstructured":"Shewhart WA. Economic control of quality of manufactured product. 1931. Reprinted by ASQC Quality Press; 1980."},{"issue":"8","key":"10642_CR3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/sim.1970","volume":"24","author":"DJ Spiegelhalter","year":"2005","unstructured":"Spiegelhalter DJ. Funnel plots for comparing institutional performance. Stat Med. 2005;24(8):1185\u2013202.","journal-title":"Stat Med."},{"issue":"3","key":"10642_CR4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1510\/icvts.2009.204768","volume":"9","author":"L Noyez","year":"2009","unstructured":"Noyez L. Control charts, Cusum techniques and funnel plots. A review of methods for monitoring performance in healthcare. Interact Cardiovasc Thorac Surg. 2009;9(3):494\u20139.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"11","key":"10642_CR5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmjqs-2016-005526","volume":"26","author":"J Neuburger","year":"2017","unstructured":"Neuburger J, Walker K, Sherlaw-Johnson C, Van Der Meulen J, Cromwell DA. Comparison of control charts for monitoring clinical performance using binary data. BMJ Qual Saf. 2017;26(11):919\u201328.","journal-title":"BMJ Qual Saf."},{"key":"10642_CR6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2010.08.131","volume":"36","author":"EFW Courrech Staal","year":"2010","unstructured":"Courrech Staal EFW, Wouters MWJM, Boot H, Tollenaar RAEM, Van Sandick JW. Quality-of-care indicators for oesophageal cancer surgery: A review. Eur J Surg Oncol. 2010;36:1035\u201343.","journal-title":"Eur J Surg Oncol."},{"key":"10642_CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1245\/s10434-012-2574-1","volume":"20","author":"JL Dikken","year":"2013","unstructured":"Dikken JL, Stiekema J, Van De Velde CJH, Verheij M, Cats A, Wouters MWJM, et al. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol. 2013;20:381\u201398.","journal-title":"Ann Surg Oncol."},{"key":"10642_CR8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1245\/s10434-013-3451-2","volume":"21","author":"L Sabater","year":"2014","unstructured":"Sabater L, Garc\u00eda-Granero A, Escrig-Sos J, del G\u00f3mez-Mateo MC, Sastre J, Ferr\u00e1ndez A, et al. Outcome quality standards in pancreatic oncologic surgery. Ann Surg Oncol. 2014;21:1138\u201346.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10642_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.breast.2011.10.003","volume":"21","author":"S Stordeur","year":"2012","unstructured":"Stordeur S, Vrijens F, Devriese S, Beirens K, Van Eycken E, Vlayen J. Developing and measuring a set of process and outcome indicators for breast cancer. Breast. 2012;21(3):253\u201360.","journal-title":"Breast."},{"issue":"8","key":"10642_CR10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ejca.2011.10.023","volume":"48","author":"J Vlayen","year":"2012","unstructured":"Vlayen J, Vrijens F, Devriese S, Beirens K, Van Eycken E, Stordeur S. Quality indicators for testicular cancer: a population-based study. Eur J Cancer. 2012;48(8):1133\u201340.","journal-title":"Eur J Cancer."},{"key":"10642_CR11","unstructured":"National Institute for Health and Care Excellence (NICE). Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. NICE; 2010."},{"key":"10642_CR12","unstructured":"Barrios P, Ramos I, Escayola C MM. Implementaci\u00f3n y desarrollo de un programa de tratamiento de la carcinomatosis peritoneal en Catalu\u00f1a. Indicaciones y resultados cl\u00ednicos con la t\u00e9cnica de Sugarbaker. Barcelona: Catalan Agency for Health Information, Evaluation and Quality (CAHIAQ -formerly CAHTA).\u00a02009"},{"key":"10642_CR13","unstructured":"National Institute for Health and Care Excellence (NICE). Colorectal cancer: diagnosis and management. NICE; 2011."},{"key":"10642_CR14","unstructured":"Cancer IN Du. Tumeur maligne, affection maligne du tissu lymphatique ou h\u00e9matopo\u00ef\u00e9tique. Cancer colorectal. Ad\u00e9nocarcinome. Haute Autorit\u00e9 de Sant\u00e9; 2012."},{"key":"10642_CR15","unstructured":"Peeters M, Leroy R, Robays J, Veereman G, Bielen D, Ceelen W, Danse E, De Man M, Demetter P, Flamen P, Hendlisz A, Sinapi I, Vanbeckevoort D, Van Cutsem E, Ysebaert D, van Gils P, Veerbeek L, Smit Y VL. Colon cancer: diagnosis, treatment and follow-up\u2014summary. Good Clinical Practice (GCP) Brussels; 2014."},{"issue":"2","key":"10642_CR16","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.3747\/co.22.2058","volume":"22","author":"P Dub\u00e9","year":"2015","unstructured":"Dub\u00e9 P, Sideris L, Law C, Mack L, Haase E, Giacomantonio C, et al. Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. Curr Oncol. 2015;22(2):e100\u201312.","journal-title":"Curr Oncol."},{"issue":"8","key":"10642_CR17","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386\u2013422.","journal-title":"Ann Oncol."},{"issue":"1","key":"10642_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdx738","volume":"29","author":"T Yoshino","year":"2018","unstructured":"Yoshino T, Arnold D, Taniguchi H, Pentheroudakis G, Yamazaki K, Xu RH, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS. SSO TOS Ann Oncol. 2018;29(1):44\u201370.","journal-title":"SSO TOS. Ann Oncol."},{"issue":"10","key":"10642_CR19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/DCR.0000000000000926","volume":"60","author":"JD Vogel","year":"2017","unstructured":"Vogel JD, Eskicioglu C, Weiser MR, Feingold DL, Steele SR. The American society of colon and rectal surgeons clinical practice guidelines for the treatment of colon cancer. Dis Colon Rectum. 2017;60(10):999\u20131017.","journal-title":"Dis Colon Rectum."},{"key":"10642_CR20","unstructured":"Morales Soriano R, Cascales Campos P GMJ. Cirug\u00eda de la carcinomatosis peritoneal. Asociaci\u00f3n Espa\u00f1ola de Cirujanos. Ar\u00e1n Edici; 2018."},{"key":"10642_CR21","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Colon Cancer. Version 3.2020. NCCN; 2020."},{"key":"10642_CR22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.dld.2019.05.035","volume":"51","author":"JM Phelip","year":"2019","unstructured":"Phelip JM, Tougeron D, L\u00e9onard D, Benhaim L, Desolneux G, Dupr\u00e9 A, et al. Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis. 2019;51:1357\u201363.","journal-title":"Dig Liver Dis."},{"issue":"4","key":"10642_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.21059","volume":"98","author":"S Kusamura","year":"2008","unstructured":"Kusamura S, Baratti D, Younan R, Deraco M. The Delphi approach to attain consensus in methodology of local regional therapy for peritoneal surface malignancy. J Surg Oncol. 2008;98(4):217\u20139.","journal-title":"J Surg Oncol."},{"issue":"4","key":"10642_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jso.21053","volume":"98","author":"J Esquivel","year":"2008","unstructured":"Esquivel J, Elias D, Baratti D, Kusamura S, Deraco M. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol. 2008;98(4):263\u20137.","journal-title":"J Surg Oncol."},{"key":"10642_CR25","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1245\/s10434-012-2496-y","volume":"19","author":"JC Bell","year":"2012","unstructured":"Bell JC, Rylah BG, Chambers RW, Peet H, Mohamed F, Moran BJ. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol. 2012;19:4244\u201351.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"10642_CR26","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","volume":"21","author":"K Turaga","year":"2014","unstructured":"Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, et al. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21(5):1501\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"10642_CR27","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","volume":"20","author":"AMJ Kuijpers","year":"2013","unstructured":"Kuijpers AMJ, Mirck B, Aalbers AGJ, Nienhuijs SW, De Hingh IHJT, Wiezer MJ, et al. Cytoreduction and HIPEC in the Netherlands: Nationwide long-term outcome following the dutch protocol. Ann Surg Oncol. 2013;20(13):4224\u201330.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"10642_CR28","doi-asserted-by":"crossref","first-page":"1.e1","DOI":"10.1016\/j.ejca.2013.06.048","volume":"50","author":"CJH Van De Velde","year":"2014","unstructured":"Van De Velde CJH, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer. 2014;50(1):1.e1-1.e34.","journal-title":"Eur J Cancer."},{"key":"10642_CR29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jso.23722","volume":"110","author":"J Esquivel","year":"2014","unstructured":"Esquivel J, Piso P, Verwaal V, Bachleitner-Hofmann T, Glehen O, Gonz\u00e1lez-Moreno S, et al. American Society of peritoneal surface malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer. J Surg Oncol. 2014;110:777\u20138.","journal-title":"J Surg Oncol."},{"key":"10642_CR30","first-page":"99","volume":"7","author":"AD Newton","year":"2016","unstructured":"Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol. 2016;7:99\u2013111.","journal-title":"J Gastrointest Oncol"},{"key":"10642_CR31","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.3748\/wjg.v22.i30.6906","volume":"22","author":"Y Li","year":"2016","unstructured":"Li Y, Zhou YF, Liang H, Wang HQ, Hao JH, Zhu ZG, et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol. 2016;22:6906\u201316.","journal-title":"World J Gastroenterol."},{"key":"10642_CR32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/codi.13593","volume":"19","author":"CEL Klaver","year":"2017","unstructured":"Klaver CEL, Groenen H, Morton DG, Laurberg S, Bemelman WA, Tanis PJ. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines. Colorectal Dis. 2017;19:224\u201336.","journal-title":"Colorectal Dis."},{"issue":"2","key":"10642_CR33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jso.24290","volume":"114","author":"IS Fr\u00f8ysnes","year":"2016","unstructured":"Fr\u00f8ysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K. Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: prognostic factors and oncologic outcome in a national patient cohort. J Surg Oncol. 2016;114(2):222\u20137.","journal-title":"J Surg Oncol."},{"issue":"6","key":"10642_CR34","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/SLA.0000000000001593","volume":"263","author":"R Kwakman","year":"2016","unstructured":"Kwakman R, Schrama AM, Van Olmen JP, Otten RH, De Lange-De Klerk ES, De Cuba EM, et al. Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases a meta-analysis. Ann Surg. 2016;263(6):1102\u201311.","journal-title":"Ann Surg."},{"key":"10642_CR35","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","volume":"43","author":"C Rasp\u00e9","year":"2017","unstructured":"Rasp\u00e9 C, Fl\u00f6ther L, Schneider R, Bucher M, Piso P. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol. 2017;43:1013\u201327.","journal-title":"Eur J Surg Oncol."},{"issue":"11","key":"10642_CR36","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ejso.2018.06.029","volume":"44","author":"CA Quadros","year":"2018","unstructured":"Quadros CA, Laporte GA, Huguenin JFL, Barreto EJSS, Barros AV, Oliveira AF, et al. Current practice of Latin American centers in the treatment of peritoneal diseases with cytoreductive surgery with HIPEC. Eur J Surg Oncol. 2018;44(11):1800\u20134.","journal-title":"Eur J Surg Oncol."},{"issue":"12","key":"10642_CR37","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","volume":"44","author":"M Bushati","year":"2018","unstructured":"Bushati M, Rovers KP, Sommariva A, Sugarbaker PH, Morris DL, Yonemura Y, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2018;44(12):1942\u20138.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"10642_CR38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jviscsurg.2019.08.002","volume":"156","author":"K Abboud","year":"2019","unstructured":"Abboud K, Andr\u00e9 T, Brunel M, Ducreux M, Eveno C, Glehen O, et al. Management of colorectal peritoneal metastases: expert opinion. J Visc Surg. 2019;156(5):377\u20139.","journal-title":"J Visc Surg."},{"issue":"9","key":"10642_CR39","first-page":"1","volume":"89","author":"CE Brett","year":"2014","unstructured":"Brett CE. My systematic review don\u2019t do it alone don\u2019t be over - (or under-) ambitious pilot, pilot, and pilot. record everything you do. Long list to short list PRISMA flowchart. Short list to review. Phys Ther. 2014;89(9):1\u20135.","journal-title":"Phys Ther"},{"issue":"8","key":"10642_CR40","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1245\/s10434-014-3563-3","volume":"21","author":"AU Blackham","year":"2014","unstructured":"Blackham AU, Russell GB, Stewart JH, Votanopoulos K, Levine EA, Shen P. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(8):2667\u201374.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10642_CR41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12029-016-9895-4","volume":"48","author":"EYT Wong","year":"2017","unstructured":"Wong EYT, Tan GHC, Ng DWJ, Koh TPT, Kumar M, Teo MCC. Surgical management of metastatic colorectal cancer: a single-centre experience on oncological outcomes of pulmonary resection vs cytoreductive surgery and HIPEC. J Gastrointest Cancer. 2017;48(4):353\u201360.","journal-title":"J Gastrointest Cancer."},{"issue":"12","key":"10642_CR42","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1245\/s10434-008-0127-4","volume":"15","author":"P Shen","year":"2008","unstructured":"Shen P, Thai K, Stewart JH, Howerton R, Loggie BW, Russell GB, et al. Peritoneal surface disease from colorectal cancer: Comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol. 2008;15(12):3422\u201332.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"10642_CR43","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jso.23545","volume":"109","author":"CQ Huang","year":"2014","unstructured":"Huang CQ, Feng JP, Yang XJ, Li Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center. J Surg Oncol. 2014;109(7):730\u20139.","journal-title":"J Surg Oncol."},{"issue":"1","key":"10642_CR44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejso.2016.09.010","volume":"43","author":"G Lorimier","year":"2017","unstructured":"Lorimier G, Linot B, Paillocher N, Dupoiron D, Verri\u00e8le V, Wernert R, et al. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. Eur J Surg Oncol. 2017;43(1):150\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"10642_CR45","first-page":"2495131","volume":"2016","author":"JL Ng","year":"2016","unstructured":"Ng JL, Ong WS, Chia CS, Tan GHC, Soo KC, Teo MCC. Prognostic relevance of the peritoneal surface disease severity score compared to the peritoneal cancer index for colorectal peritoneal carcinomatosis. Int J Surg Oncol. 2016;2016:2495131.","journal-title":"Int J Surg Oncol."},{"issue":"9","key":"10642_CR46","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Color Dis. 2015;17(9):772\u20138.","journal-title":"Color Dis."},{"issue":"5","key":"10642_CR47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jso.24169","volume":"113","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, Van Oudheusden TR, Braam HJ, Wiezer MJ, Nienhuijs SW, Rutten HJ, et al. Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study. J Surg Oncol. 2016;113(5):548\u201353.","journal-title":"J Surg Oncol."},{"issue":"16","key":"10642_CR48","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284\u201392.","journal-title":"J Clin Oncol."},{"issue":"6","key":"10642_CR49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","volume":"203","author":"RG da Silva","year":"2006","unstructured":"da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg. 2006;203(6):878\u201386.","journal-title":"J Am Coll Surg."},{"issue":"5","key":"10642_CR50","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1245\/s10434-009-0866-x","volume":"17","author":"TC Chua","year":"2010","unstructured":"Chua TC, Morris DL, Esquivel J. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17(5):1330\u20136.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"10642_CR51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","volume":"37","author":"F Cavaliere","year":"2011","unstructured":"Cavaliere F, De Simone M, Virz S, Deraco M, Rossi CR, Garofalo A, et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol. 2011;37(2):148\u201354.","journal-title":"Eur J Surg Oncol."},{"issue":"13","key":"10642_CR52","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1245\/s10434-011-1793-1","volume":"18","author":"AR Hill","year":"2011","unstructured":"Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH, Levine EA. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol. 2011;18(13):3673\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"10642_CR53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e318255486a","volume":"256","author":"G Passot","year":"2012","unstructured":"Passot G, Vaudoyer D, Cotte E, You B, Isaac S, No\u00ebl Gilly F, et al. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg. 2012;256(1):125\u20139.","journal-title":"Ann Surg."},{"issue":"5","key":"10642_CR54","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s11605-014-2477-5","volume":"18","author":"P Tabrizian","year":"2014","unstructured":"Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. 2014;18(5):1024\u201331.","journal-title":"J Gastrointest Surg."},{"issue":"1","key":"10642_CR55","first-page":"295","volume":"35","author":"HJ Braam","year":"2015","unstructured":"Braam HJ, Van Oudheusden TR, De Hingh IHJT, Nienhuijs SW, Boerma D, Wiezer MJ, et al. Urological procedures in patients with peritoneal carcinomatosis of colorectal cancer treated with HIPEC: morbidity and survival analysis. Anticancer Res. 2015;35(1):295\u2013300.","journal-title":"Anticancer Res."},{"issue":"4","key":"10642_CR56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"EA Levine","year":"2014","unstructured":"Levine EA, Stewart JH IV, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573\u201385.","journal-title":"J Am Coll Surg."},{"issue":"9","key":"10642_CR57","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Go\u00e9r\u00e9","year":"2015","unstructured":"Go\u00e9r\u00e9 D, Souadka A, Faron M, Cloutier AS, Viana B, Honor\u00e9 C, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22(9):2958\u201364.","journal-title":"Ann Surg Oncol."},{"issue":"Suppl 5","key":"10642_CR58","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1245\/s10434-016-5547-y","volume":"23","author":"RM Dodson","year":"2016","unstructured":"Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, et al. Quality-of-life evaluation after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(Suppl 5):772\u201383.","journal-title":"Ann Surg Oncol."},{"issue":"S5","key":"10642_CR59","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1245\/s10434-016-5543-2","volume":"23","author":"J Navez","year":"2016","unstructured":"Navez J, Remue C, Leonard D, Bachmann R, Kartheuser A, Hubert C, et al. Surgical treatment of colorectal cancer with peritoneal and liver metastases using combined liver and cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: report from a single-centre experience. Ann Surg Oncol. 2016;23(S5):666\u201373.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10642_CR60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jso.24543","volume":"115","author":"A Saxena","year":"2017","unstructured":"Saxena A, Valle SJ, Liauw W, Morris DL. Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;115(4):417\u201324.","journal-title":"J Surg Oncol."},{"issue":"12","key":"10642_CR61","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1245\/s10434-017-6042-9","volume":"24","author":"K Demey","year":"2017","unstructured":"Demey K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, Vandecaveye V, Van Cutsem E, et al. External validation of the prognostic nomogram (COMPASS) for patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2017;24(12):3604\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"10642_CR62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1245\/ASO.2004.05.009","volume":"11","author":"P Shen","year":"2004","unstructured":"Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol. 2004;11(2):178\u201386.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"10642_CR63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","volume":"23","author":"M Faron","year":"2016","unstructured":"Faron M, Macovei R, Go\u00e9r\u00e9 D, Honor\u00e9 C, Benhaim L, Elias D. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23(1):114\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"10642_CR64","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","volume":"57","author":"D Baratti","year":"2014","unstructured":"Baratti D, Kusamura S, Iusco D, Bonomi S, Grassi A, Virz\u00ec S, et al. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum. 2014;57(7):858\u201368.","journal-title":"Dis Colon Rectum."},{"issue":"4","key":"10642_CR65","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.sla.0000255561.87771.11","volume":"245","author":"R Kianmanesh","year":"2007","unstructured":"Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245(4):597\u2013603.","journal-title":"Ann Surg."},{"issue":"6","key":"10642_CR66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejso.2012.03.001","volume":"38","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol. 2012;38(6):509\u201315.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"10642_CR67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","volume":"254","author":"F Quenet","year":"2011","unstructured":"Quenet F, Go\u00e9r\u00e9 D, Mehta SS, Roca L, Dumont F, Hessissen M, et al. Results of two Bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg. 2011;254(2):294\u2013301.","journal-title":"Ann Surg."},{"issue":"13","key":"10642_CR68","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-014-3798-z","volume":"21","author":"J Esquivel","year":"2014","unstructured":"Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, et al. The American Society of Peritoneal Surface Malignancies (ASPSM) multiinstitution evaluation of the peritoneal surface disease severity score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis. Ann Surg Oncol. 2014;21(13):4195\u2013201.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"10642_CR69","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10147-017-1092-3","volume":"22","author":"TSH Bong","year":"2017","unstructured":"Bong TSH, Tan GHC, Chia C, Soo KC, Teo MCC. Preoperative platelet\u2013lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Clin Oncol. 2017;22(3):511\u20138.","journal-title":"Int J Clin Oncol."},{"issue":"4","key":"10642_CR70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jso.24911","volume":"117","author":"MA Kozman","year":"2018","unstructured":"Kozman MA, Fisher OM, Rebolledo BAJ, Parikh R, Valle SJ, Arrowaili A, et al. CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: a retrospective cohort study. J Surg Oncol. 2018;117(4):725\u201336.","journal-title":"J Surg Oncol."},{"issue":"9","key":"10642_CR71","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/DCR.0000000000001156","volume":"61","author":"D Baratti","year":"2018","unstructured":"Baratti D, Kusamura S, Iusco D, Cotsoglou C, Guaglio M, Battaglia L, et al. Should a history of extraperitoneal disease be a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer peritoneal metastases? Dis Colon Rectum. 2018;61(9):1026\u201334.","journal-title":"Dis Colon Rectum."},{"issue":"24","key":"10642_CR72","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer. 2010;116(24):5608\u201318.","journal-title":"Cancer."},{"key":"10642_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/978394","volume":"2013","author":"Y Yonemura","year":"2013","unstructured":"Yonemura Y, Canbay E, Ishibashi H. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. Sci World J. 2013;2013:1\u20137.","journal-title":"Sci World J."},{"key":"10642_CR74","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00432-013-1483-4","volume":"139","author":"TC Wehler","year":"2013","unstructured":"Wehler TC, Graf C, M\u00f6hler M, Herzog JR, Berger M, Gockel I, et al. Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective. J Cancer Res Clin Oncol. 2013;139:1961\u20132. https:\/\/doi.org\/10.1007\/s00432-013-1483-4.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"5","key":"10642_CR75","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00423-013-1065-6","volume":"398","author":"I K\u00f6nigsrainer","year":"2013","unstructured":"K\u00f6nigsrainer I, Horvath P, Struller F, Forkl V, K\u00f6nigsrainer A, Beckert S. Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies. Langenbeck\u2019s Arch Surg. 2013;398(5):745\u20139.","journal-title":"Langenbeck\u2019s Arch Surg."},{"issue":"1","key":"10642_CR76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00423-014-1253-z","volume":"400","author":"M Desantis","year":"2015","unstructured":"Desantis M, Bernard JL, Casanova V, Cegarra-Escolano M, Benizri E, Rahili AM, et al. Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbeck\u2019s Arch Surg. 2015;400(1):37\u201348.","journal-title":"Langenbeck\u2019s Arch Surg."},{"issue":"11","key":"10642_CR77","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","volume":"40","author":"D Elias","year":"2014","unstructured":"Elias D, Mariani A, Cloutier AS, Blot F, Go\u00e9r\u00e9 D, Dumont F, et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol. 2014;40(11):1467\u201373.","journal-title":"Eur J Surg Oncol."},{"issue":"11","key":"10642_CR78","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/ans.13152","volume":"86","author":"N Alzahrani","year":"2016","unstructured":"Alzahrani N, Ferguson JS, Valle SJ, Liauw W, Chua T, Morris DL. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia. ANZ J Surg. 2016;86(11):937\u201341.","journal-title":"ANZ J Surg."},{"issue":"1","key":"10642_CR79","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12957-015-0682-7","volume":"13","author":"Y Huang","year":"2015","unstructured":"Huang Y, Alzahrani NA, Alzahrani SE, Zhao J, Liauw W, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly. World J Surg Oncol. 2015;13(1):262.","journal-title":"World J Surg Oncol."},{"issue":"3","key":"10642_CR80","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/s10434-015-4914-4","volume":"23","author":"M Maillet","year":"2016","unstructured":"Maillet M, Glehen O, Lambert J, Goere D, Pocard M, Msika S, et al. Early postoperative chemotherapy after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for isolated peritoneal carcinomatosis of colon cancer: a multicenter study. Ann Surg Oncol. 2016;23(3):863\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10642_CR81","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-016-5698-x","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C, Sugarbaker PH. Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy: a single institution\u2019s experience during two decades. Ann Surg Oncol. 2017 ;24(4):898\u2013905.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"10642_CR82","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jso.24248","volume":"113","author":"G Passot","year":"2016","unstructured":"Passot G, Vaudoyer D, Villeneuve L, Kepenekian V, Beaujard A-C, Bakrin N, et al. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol. 2016 ;113(7):796\u2013803.","journal-title":"J Surg Oncol."},{"issue":"5","key":"10642_CR83","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/02656736.2017.1371342","volume":"34","author":"N Banaste","year":"2018","unstructured":"Banaste N, Rousset P, Mercier F, Rieussec C, Valette PJ, Glehen O, et al. Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. Int J Hyperth. 2018 ;34(5):589\u201394.","journal-title":"Int J Hyperth."},{"issue":"10","key":"10642_CR84","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/COC.0000000000000414","volume":"41","author":"A Saxena","year":"2018","unstructured":"Saxena A, Liauw W, Virk SA, Morris DL. Impact of concomitant urologic intervention on clinical outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Am J Clin Oncol Cancer Clin Trials. 2018;41(10):943\u20138.","journal-title":"Am J Clin Oncol Cancer Clin Trials."},{"issue":"2","key":"10642_CR85","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.amjsurg.2016.03.008","volume":"213","author":"D Massalou","year":"2017","unstructured":"Massalou D, Benizri E, Chevallier A, Duranton-Tanneur V, Pedeutour F, Benchimol D, et al. Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes. Am J Surg. 2017;213(2):377\u201387.","journal-title":"Am J Surg."},{"issue":"8","key":"10642_CR86","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1245\/s10434-018-6539-x","volume":"25","author":"NR Sluiter","year":"2018","unstructured":"Sluiter NR, Rovers KP, Salhi Y, Vlek SL, Coup\u00e9 VMH, Verheul HMW, et al. Metachronous peritoneal metastases after adjuvant chemotherapy are associated with poor outcome after cytoreduction and HIPEC. Ann Surg Oncol. 2018;25(8):2347\u201356.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"10642_CR87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/02656736.2016.1262064","volume":"33","author":"G Tan","year":"2017","unstructured":"Tan G, Chia C, Kumar M, Choo SP, Chia J, Tham CK, et al. 201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre. Int J Hyperth. 2017;33(3):288\u201394.","journal-title":"Int J Hyperth."},{"issue":"2","key":"10642_CR88","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jso.24632","volume":"116","author":"L Lee","year":"2017","unstructured":"Lee L, Alie-Cusson F, Dub\u00e9 P, Sideris L. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. J Surg Oncol. 2017;116(2):236\u201343.","journal-title":"J Surg Oncol."},{"issue":"9","key":"10642_CR89","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1245\/s10434-016-5214-3","volume":"23","author":"RA Devilee","year":"2016","unstructured":"Devilee RA, Simkens GA, van Oudheusden TR, Rutten HJ, Creemers GJ, ten Tije AJ, et al. Increased survival of patients with synchronous colorectal peritoneal metastases receiving preoperative chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(9):2841\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"10642_CR90","first-page":"747","volume":"20","author":"F Cavaliere","year":"2006","unstructured":"Cavaliere F, Valle M, DeSimone M, Deraco M, Rossi CR, DiFilippo F, et al. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia. A S.I.T.I.L.O. multicentric study. in Vivo (Brooklyn). 2006;20(6):747\u201350.","journal-title":"in Vivo (Brooklyn)."},{"issue":"8","key":"10642_CR91","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1245\/s10434-007-9410-z","volume":"14","author":"L Bijelic","year":"2007","unstructured":"Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2007;14(8):2281\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"10642_CR92","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00268-009-0206-0","volume":"34","author":"A Saxena","year":"2010","unstructured":"Saxena A, Yan TD, Morris DL. A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. World J Surg. 2010;34(1):70\u20138.","journal-title":"World J Surg."},{"issue":"6","key":"10642_CR93","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1245\/s10434-013-3442-3","volume":"21","author":"C Eveno","year":"2014","unstructured":"Eveno C, Passot G, Go\u00e9r\u00e9 D, Soyer P, Gayat E, Glehen O, et al. Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2014;21(6):1792\u2013800.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10642_CR94","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1245\/s10434-012-2787-3","volume":"20","author":"KI Votanopoulos","year":"2013","unstructured":"Votanopoulos KI, Swett K, Blackham AU, Ihemelandu C, Shen P, Stewart JH, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer. Ann Surg Oncol. 2013;20(4):1088\u201392.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10642_CR95","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","volume":"110","author":"A Prada-Villaverde","year":"2014","unstructured":"Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, et al. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014;110(7):779\u201385.","journal-title":"J Surg Oncol."},{"issue":"2","key":"10642_CR96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jso.23446","volume":"109","author":"JD Rivard","year":"2014","unstructured":"Rivard JD, McConnell YJ, Temple WJ, Mack LA. Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: Are we excluding patients who may benefit? J Surg Oncol. 2014;109(2):104\u20139.","journal-title":"J Surg Oncol."},{"issue":"2","key":"10642_CR97","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.23784","volume":"111","author":"TR Van Oudheusden","year":"2015","unstructured":"Van Oudheusden TR, Braam HJ, Nienhuijs SW, Wiezer MJ, Van Ramshorst B, Luyer P, et al. Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology. J Surg Oncol. 2015;111(2):237\u201342.","journal-title":"J Surg Oncol."},{"issue":"2","key":"10642_CR98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jso.23610","volume":"110","author":"PH Cashin","year":"2014","unstructured":"Cashin PH, Dranichnikov F, Mahteme H. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate. J Surg Oncol. 2014;110(2):203\u20136.","journal-title":"J Surg Oncol."},{"issue":"8","key":"10642_CR99","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","volume":"21","author":"G Passot","year":"2014","unstructured":"Passot G, You B, Boschetti G, Fontaine J, Isaac S, Decullier E, et al. Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Ann Surg Oncol. 2014;21(8):2608\u201314.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"10642_CR100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","volume":"23","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, et al. Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2016;23(3):833\u201341.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"10642_CR101","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejso.2016.09.015","volume":"43","author":"V Leung","year":"2017","unstructured":"Leung V, Huo YR, Liauw W, Morris DL. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43(1):144\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"10642_CR102","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jss.2017.05.126","volume":"219","author":"S Downs-Canner","year":"2017","unstructured":"Downs-Canner S, Shuai Y, Ramalingam L, Pingpank JF, Holtzman MP, Zeh HJ, et al. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases. J Surg Res. 2017;219:194\u2013201.","journal-title":"J Surg Res."},{"issue":"5","key":"10642_CR103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/DCR.0000000000000774","volume":"60","author":"WJ Van Eden","year":"2017","unstructured":"Van Eden WJ, Kok NF, J\u00f3\u017awiak K, Lahaye ML, Beets GL, Van Leerdam ME, et al. Timing of systemic chemotherapy in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Dis Colon Rectum. 2017;60(5):477\u201387.","journal-title":"Dis Colon Rectum."},{"issue":"5","key":"10642_CR104","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000490068","volume":"36","author":"FMK Elekonawo","year":"2019","unstructured":"Elekonawo FMK, Van Der Meeren MMD, Simkens GA, De Wilt JHW, De Hingh IH, Bremers AJA. Comparison of 2 perioperative management protocols and their influence on postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: standard parenteral nutrition, selective bowel decontamination and suprapubic cathe. Dig Surg. 2019;36(5):394\u2013401.","journal-title":"Dig Surg."},{"issue":"3","key":"10642_CR105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"BK Paul","year":"2018","unstructured":"Paul BK, Ihemelandu C, Sugarbaker PH. Prior surgical score: An analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemoth. Dis Colon Rectum. 2018;61(3):347\u201354.","journal-title":"Dis Colon Rectum."},{"issue":"7","key":"10642_CR106","first-page":"77","volume":"23","author":"NC Arslan","year":"2018","unstructured":"Arslan NC, Bisgin T, Altay C, Yavuzsen T, Karaoglu A, Canda AE, et al. Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer? J BUON. 2018;23(7):77\u201383.","journal-title":"J BUON."},{"issue":"6","key":"10642_CR107","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/bjs.4473","volume":"91","author":"O Glehen","year":"2004","unstructured":"Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg. 2004;91(6):747\u201354.","journal-title":"Br J Surg."},{"issue":"15","key":"10642_CR108","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1002\/cncr.24385","volume":"115","author":"O Varban","year":"2009","unstructured":"Varban O, Levine EA, Stewart JH, McCoy TP, Shen P. Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer. 2009;115(15):3427\u201336.","journal-title":"Cancer."},{"issue":"6","key":"10642_CR109","first-page":"551","volume":"68","author":"M Robella","year":"2013","unstructured":"Robella M, Vaira M, Marsanic P, Mellano A, Cinquegrana A, Sottile A, et al. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients. Minerva Chir. 2013;68(6):551\u20138.","journal-title":"Minerva Chir."},{"issue":"12","key":"10642_CR110","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1245\/s10434-016-5360-7","volume":"23","author":"S Chemama","year":"2016","unstructured":"Chemama S, Bayar MA, Lanoy E, Ammari S, Stoclin A, Go\u00e9r\u00e9 D, et al. Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2016;23(12):3891\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"10642_CR111","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1245\/s10434-016-5211-6","volume":"23","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Nieboer D, Steyerberg EW, Rutten HJ, Luyer MD, et al. Development of a prognostic nomogram for patients with peritoneally metastasized colorectal cancer treated with cytoreductive surgery and HIPEC. Ann Surg Oncol. 2016;23(13):4214\u201321.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"10642_CR112","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1245\/s10434-008-0105-x","volume":"15","author":"J Franko","year":"2008","unstructured":"Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, Zeh HJ, et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol. 2008;15(11):3065\u201372.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"10642_CR113","doi-asserted-by":"crossref","first-page":"e108509","DOI":"10.1371\/journal.pone.0108509","volume":"9","author":"C-Q Huang","year":"2014","unstructured":"Huang C-Q, Yang X-J, Yu Y, Wu H-T, Liu Y, Yonemura Y, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese Center. PLoS ONE. 2014;9(9):e108509.","journal-title":"PLoS ONE"},{"issue":"1","key":"10642_CR114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1245\/s10434-015-4699-5","volume":"23","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Braam HJ, Luyer MD, Wiezer MJ, van Ramshorst B, et al. Treatment-related mortality after cytoreductive surgery and HIPEC in patients with colorectal peritoneal carcinomatosis is underestimated by conventional parameters. Ann Surg Oncol. 2016;23(1):99\u2013105.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"10642_CR115","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"GA Simkens","year":"2015","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22(8):2656\u201362.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"10642_CR116","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-016-5143-1","volume":"23","author":"T Charrier","year":"2016","unstructured":"Charrier T, Passot G, Peron J, Maurice C, Gocevska S, Qu\u00e9net F, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with oxaliplatin increases the risk of postoperative hemorrhagic complications: analysis of predictive factors. Ann Surg Oncol. 2016;23(7):2315\u201322.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"10642_CR117","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.suronc.2016.05.025","volume":"25","author":"SJ Valle","year":"2016","unstructured":"Valle SJ, Alzahrani N, Alzahrani S, Bin TT, Liauw W, Morris DL. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: incidence, management and outcomes. Surg Oncol. 2016;25(3):315\u201320.","journal-title":"Surg Oncol"},{"issue":"4","key":"10642_CR118","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1245\/s10434-016-5738-6","volume":"24","author":"K Chouliaras","year":"2017","unstructured":"Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI. Prognostic factors and significance of gastrointestinal leak after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2017;24(4):890\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"10642_CR119","first-page":"2621","volume":"21","author":"TR Van Oudheusden","year":"2014","unstructured":"Van Oudheusden TR, Braam HJ, Nienhuijs SW, Wiezer MJ, Van Ramshorst B, Luyer MD, et al. Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis. Ann Surg Oncol. 2014;21(8):2621\u20136.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"10642_CR120","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ejso.2013.08.006","volume":"39","author":"D Elias","year":"2013","unstructured":"Elias D, Borget I, Farron M, Dromain C, Ducreux M, Go\u00e9r\u00e9 D, et al. Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers. Eur J Surg Oncol. 2013;39(11):1214\u20138.","journal-title":"Eur J Surg Oncol."},{"issue":"8","key":"10642_CR121","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejso.2014.02.238","volume":"40","author":"AMJ Kuijpers","year":"2014","unstructured":"Kuijpers AMJ, Mehta AM, Aalbers AGJ, van Driel WJ, Boot H, Verwaal VJ. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2014;40(8):937\u201342.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"10642_CR122","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02287824","volume":"27","author":"NA Dewan","year":"2000","unstructured":"Dewan NA, Daniels A, Zieman G, Kramer T. The national outcomes management project: a benchmarking collaborative. J Behav Heal Serv Res. 2000;27(4):431\u20136.","journal-title":"J Behav Heal Serv Res."},{"key":"10642_CR123","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2934.2006.00596.x","volume":"14","author":"J Ellis","year":"2006","unstructured":"Ellis J. All inclusive benchmarking . J Nurs Manag. 2006;14:377\u201383.","journal-title":"J Nurs Manag"},{"key":"10642_CR124","unstructured":"Salazar G de. Benchmarking y marketing en cirug\u00eda. In: Aguil\u00f3 Lucia SA (ed). Gesti\u00f3n Cl\u00ednica en Cirug\u00eda. Aran Ediciones; 2016. pp. 393\u2013404."},{"key":"10642_CR125","unstructured":"J AL, V. SA. Gesti\u00f3n cl\u00ednica en cirug\u00eda. Ediciones A (ed). 2016."},{"issue":"2","key":"10642_CR126","first-page":"94","volume":"27","author":"J Escrig-Sos","year":"2014","unstructured":"Escrig-Sos J. M\u00e9todos actuales para la monitorizaci\u00f3n y control de calidad de los procesos cl\u00ednicos. Rev Senol Patol Mamar. 2014;27(2):94\u20138.","journal-title":"Rev Senol Patol Mamar."},{"issue":"2","key":"10642_CR127","first-page":"94","volume":"27","author":"M Pera","year":"2003","unstructured":"Pera M. Niveles de calidad exigibles en cuanto a tecnolog\u00eda y procedimientos en la cirug\u00eda del c\u00e1ncer de es\u00f3fago. Cir Esp. 2003;27(2):94\u20138.","journal-title":"Cir Esp."},{"issue":"2","key":"10642_CR128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ciresp.2015.11.009","volume":"94","author":"H Ortiz","year":"2016","unstructured":"Ortiz H, Codina A. Proyecto del c\u00e1ncer de recto de la Asociaci\u00f3n Espa\u00f1ola de Cirujanos (Vikingo): Pasado y futuro. Cirug\u00eda Espa\u00f1ola. 2016;94(2):63\u20134.","journal-title":"Cirug\u00eda Espa\u00f1ola."},{"issue":"11","key":"10642_CR129","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archoto.2011.177","volume":"137","author":"TD Shellenberger","year":"2011","unstructured":"Shellenberger TD, Madero-Visbal R, Weber RS. Quality indicators in head and neck operations: a comparison with published benchmarks. Arch Otolaryngol Head Neck Surg. 2011;137(11):1086\u201393.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"issue":"6","key":"10642_CR130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00423-020-01908-w","volume":"405","author":"M Bellver Oliver","year":"2020","unstructured":"Bellver Oliver M, Escrig-Sos J, Rotellar Sastre F, Moya-Herr\u00e1iz \u00c1, Sabater-Ort\u00ed L. Outcome quality standards for surgery of colorectal liver metastasis. Langenbeck\u2019s Arch Surg. 2020;405(6):745\u201356.","journal-title":"Langenbeck\u2019s Arch Surg."},{"issue":"12","key":"10642_CR131","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/jcm7120567","volume":"7","author":"C Yurttas","year":"2018","unstructured":"Yurttas C, Hoffmann G, Tolios A, Haen SP, Schwab M, K\u00f6nigsrainer I, et al. Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer. J Clin Med. 2018;7(12):567.","journal-title":"J Clin Med."},{"issue":"34","key":"10642_CR132","doi-asserted-by":"crossref","first-page":"8664","DOI":"10.1200\/JCO.2005.01.6071","volume":"23","author":"DJ Sargent","year":"2005","unstructured":"Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2005;23(34):8664\u201370.","journal-title":"J Clin Oncol."},{"key":"10642_CR133","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/djm024","volume":"99","author":"CJA Punt","year":"2007","unstructured":"Punt CJA, Buyse M, K\u00f6hne CH, Hohenberger P, Labianca R, Schmoll HJ, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007;99:998\u20131003.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10642_CR134","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS open. 2019;3(5):585\u201394.","journal-title":"BJS open."},{"issue":"8","key":"10642_CR135","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1245\/s10434-007-9406-8","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Links M, Fransi S, Jacques T, Black D, Saunders V, et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy\u2014a journey to becoming a nationally funded peritonectomy center. Ann Surg Oncol. 2007;14(8):2270\u201380.","journal-title":"Ann Surg Oncol."},{"key":"10642_CR136","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/sur.2017.089","volume":"18","author":"H Cheng","year":"2017","unstructured":"Cheng H, Chen BPH, Soleas IM, Ferko NC, Cameron CG, Hinoul P. Prolonged operative duration increases risk of surgical site infections: a systematic review. Surg Infect. 2017;18:722\u201335.","journal-title":"Surg Infect."},{"issue":"2","key":"10642_CR137","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","volume":"149","author":"MD Jafari","year":"2014","unstructured":"Jafari MD, Halabi WJ, Stamos MJ, Nguyen VQ, Carmichael JC, Mills SD, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program. JAMA Surg. 2014;149(2):170\u20135.","journal-title":"JAMA Surg."},{"key":"10642_CR138","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jss.2018.09.032","volume":"234","author":"F Gani","year":"2019","unstructured":"Gani F, Conca-Cheng AM, Nettles B, Ahuja N, Johnston FM. Trends in outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Res. 2019;234:240\u20138.","journal-title":"J Surg Res."},{"issue":"7","key":"10642_CR139","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00005650-199207000-00004","volume":"30","author":"JH Silber","year":"1992","unstructured":"Silber JH, Williams SV, Krakauer H, Schwartz JS. Hospital and patient characteristics associatedwith death after surgery: a study of adverse occurrence and failure to rescue. Med Care. 1992;30(7):615\u201327.","journal-title":"Med Care."},{"issue":"1","key":"10642_CR140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/SLA.0000000000001917","volume":"266","author":"NN Massarweh","year":"2017","unstructured":"Massarweh NN, Anaya DA, Kougias P, Bakaeen FG, Awad SS, Berger DH. Variation and impact of multiple complications on failure to rescue after inpatient surgery. Ann Surg. 2017;266(1):59\u201365.","journal-title":"Ann Surg."},{"issue":"Suppl 1","key":"10642_CR141","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13193-019-00877-x","volume":"10","author":"S Sinukumar","year":"2019","unstructured":"Sinukumar S, Mehta S, Damodaran D, Rajan F, Zaveri S, Ray M, et al. Failure-to-rescue following cytoreductive surgery with or without HIPEC is determined by the type of complication\u2014a retrospective study by INDEPSO. Indian J Surg Oncol. 2019;10(Suppl 1):71\u20139.","journal-title":"Indian J Surg Oncol."},{"key":"10642_CR142","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jss.2017.02.048","volume":"214","author":"KY Li","year":"2017","unstructured":"Li KY, Mokdad AA, Minter RM, Mansour JC, Choti MA, Augustine MM, et al. Failure to rescue following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2017;214:209\u201315.","journal-title":"J Surg Res."},{"issue":"4","key":"10642_CR143","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/SLA.0000000000001723","volume":"265","author":"G Passot","year":"2017","unstructured":"Passot G, Vaudoyer D, Villeneuve L, Wallet F, Beaujard AC, Boschetti G, et al. A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis. Ann Surg. 2017;265(4):806\u201313.","journal-title":"Ann Surg"},{"issue":"13","key":"10642_CR144","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1245\/s10434-020-08815-w","volume":"27","author":"JB Liu","year":"2020","unstructured":"Liu JB, Schuitevoerder D, Vining CC, Berger Y, Turaga KK, Eng OS. Benchmarking perioperative outcomes of cytoreductive surgery for cancer: implications for quality measurement. Ann Surg Oncol. 2020;27(13):5039\u201346.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10642_CR145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archsurg.136.4.405","volume":"136","author":"JD Birkmeyer","year":"2001","unstructured":"Birkmeyer JD, Hamby LS, Birkmeyer CM, Decker MV, Karon NM, Dow RW. Is unplanned return to the operating room a useful quality indicator in general surgery? Arch Surg. 2001;136(4):405\u201311.","journal-title":"Arch Surg."},{"issue":"5","key":"10642_CR146","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00423-019-01808-8","volume":"404","author":"S Blaj","year":"2019","unstructured":"Blaj S, Nedelcut S, Mayr M, Leebmann H, Leucuta D, Glockzin G, et al. Re-operations for early postoperative complications after CRS and HIPEC: indication, timing, procedure, and outcome. Langenbeck\u2019s Arch Surg. 2019;404(5):541\u20136.","journal-title":"Langenbeck\u2019s Arch Surg."},{"issue":"6","key":"10642_CR147","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ciresp.2018.03.002","volume":"96","author":"L Sabater","year":"2018","unstructured":"Sabater L, Mora I, G\u00e1mez del Castillo JM, Escrig-Sos J, Mu\u00f1oz-Forner E, Garc\u00e9s-Albir M, et al. Outcome quality standards in pancreatic oncologic surgery in Spain. Cir Esp. 2018;96(6):342\u201351.","journal-title":"Cir Esp"},{"issue":"6","key":"10642_CR148","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejso.2016.03.014","volume":"42","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, Razenberg LG, Lemmens VE, Rutten HJ, Creemers GJ, de Hingh IH. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases. Eur J Surg Oncol. 2016;42(6):794\u2013800.","journal-title":"Eur J Surg Oncol."},{"issue":"8","key":"10642_CR149","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s11605-017-3444-8","volume":"21","author":"A Saxena","year":"2017","unstructured":"Saxena A, Valle SJ, Liauw W, Morris DL. Allogenic blood transfusion is an independent predictor of poorer peri-operative outcomes and reduced long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of 936 cases. J Gastrointest Surg. 2017 ;21(8):1318\u201327.","journal-title":"J Gastrointest Surg."},{"issue":"4","key":"10642_CR150","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1245\/s10434-016-5693-2","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C. Inflammation-based prognostic scores: utility in prognostication and patient selection for cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal metastasis of colonic origin. Ann Surg Oncol. 2017;24(4):884\u20139.","journal-title":"Ann Surg Oncol."},{"key":"10642_CR151","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-0-387-48993-3_15","volume-title":"Peritoneal carcinomatosis: a multidisciplinary approach","author":"PH Sugarbaker","year":"2007","unstructured":"Sugarbaker PH. Peritonectomy procedures. In: PH Sugarbaker, editor. Peritoneal carcinomatosis: a multidisciplinary approach. Springer; 2007. p. 247\u201364."},{"issue":"1","key":"10642_CR152","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol. 2007;14(1):128\u201333.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"10642_CR153","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejso.2015.08.162","volume":"42","author":"AM Kuijpers","year":"2016","unstructured":"Kuijpers AM, Hauptmann M, Aalbers AG, Nienhuijs SW, De Hingh IH, Wiezer MJ, et al. Cytoreduction and hyperthermic intraperitoneal chemotherapy: the learning curve reassessed. Eur J Surg Oncol. 2016;42(2):244\u201350.","journal-title":"Eur J Surg Oncol."},{"key":"10642_CR154","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"issue":"3","key":"10642_CR155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.surg.2009.10.012","volume":"147","author":"NN Rahbari","year":"2010","unstructured":"Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147(3):339\u201351.","journal-title":"Surgery."},{"issue":"2","key":"10642_CR156","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0196-6553(99)70088-X","volume":"27","author":"AJ Mangram","year":"1999","unstructured":"Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27(2):97\u2013132.","journal-title":"Am J Infect Control."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10642-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10642-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10642-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T06:53:58Z","timestamp":1725692038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10642-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10642"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10642-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alfonso Garc\u00eda-Fadrique, Rafael Estevan Estevan, and Luis Sabater Ort\u00ed declare no conflicts of interest.\u00a0In loving memory of Prof. Javier Escrig Sos MD PhD.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}